Follow
Yugandhara Jirwankar
Yugandhara Jirwankar
National Center for Preclinical Reproductive and Genetic Toxicology, ICMR- National Institute for Research in Reproductive and Child Health
Verified email at nirrch.res.in
Title
Cited by
Cited by
Year
Long-Acting Efavirenz and HIV-1 Fusion Inhibitor Peptide Co-loaded Polymer–Lipid Hybrid Nanoparticles: Statistical Optimization, Cellular Uptake, and In Vivo Biodistribution
DH Surve, YB Jirwankar, VD Dighe, AB Jindal
Molecular Pharmaceutics 17 (10), 3990-4003, 2020
172020
Evaluation of pharmacokinetics, biodistribution, and antimalarial efficacy of artemether-loaded polymeric nanorods
AR Bhide, M Suri, S Katnoria, S Kaur, YB Jirwankar, VD Dighe, AB Jindal
Molecular Pharmaceutics 20 (1), 118-127, 2022
62022
Identification and validation of Sertoli cell homing peptides as molecular steering for testis targeted drug delivery
Y Jirwankar, V Dighe
Journal of Drug Targeting 31 (4), 390-401, 2023
22023
Phage Display Identified Novel Leydig Cell Homing Peptides for Testicular Targeting
Y Jirwankar, A Nair, S Marathe, V Dighe
ACS Pharmacology & Translational Science 7 (3), 809-822, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–4